Cabot Corporation

NYSE:CBT Voorraadrapport

Marktkapitalisatie: US$4.3b

Cabot Inkomsten in het verleden

Verleden criteriumcontroles 2/6

Cabot heeft de winst zien groeien met een gemiddeld jaarlijks percentage van 25.8%, terwijl de Chemicals-industrie de winst zag dalen met 4% per jaar. De inkomsten zijn gegroeid met een gemiddeld jaarlijks percentage van 1.6%. Het rendement op eigen vermogen van Cabot is 19.4%, en het heeft een nettomarge van 7.9%.

Belangrijke informatie

25.81%

Groei van de winst

26.74%

Groei van de winst per aandeel

Chemicals Groei van de industrie12.93%
Inkomstengroei1.65%
Rendement op eigen vermogen19.38%
Nettomarge7.86%
Laatste winstupdate31 Mar 2026

Recente prestatie-updates uit het verleden

Recent updates

Nieuw narratief Jun 09

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?
Seeking Alpha Mar 26

Cabot: Competitive Pressures Due To High Tire Imports Continuing To Weigh

Summary Cabot Corporation continues to face sustained volume pressure in both Reinforcement Materials and Performance Chemicals, with management candid about ongoing macro headwinds. Despite Battery Materials revenue strength, EBIT in CBT's largest segment dropped by $28 million, and cost-cutting plus reduced capex signal a defensive near-term posture. Earnings are expected to fall by approximately 14% in fiscal 2026, with further downside risk due to recent downward EPS revisions and capacity rationalization plans. Technical analysis suggests the stock is consolidating at best, with broken support levels and weakening momentum likely leading to further downside; we maintain a bearish stance. Read the full article on Seeking Alpha
Analyseartikel Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Analyseartikel Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Analyseartikel Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Analyseartikel Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Analyseartikel Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Analyseartikel Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Analyseartikel Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Analyseartikel Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analyseartikel Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Analyseartikel Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analyseartikel Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
Analyseartikel Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Analyseartikel Sep 25

Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Analyseartikel Aug 19

Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)

Key Insights The projected fair value for Cabot is US$96.50 based on 2 Stage Free Cash Flow to Equity With US$99.26...
Seeking Alpha Jul 31

Cabot Corporation: Now A 'Hold' (Rating Downgrade)

Summary Cabot Corporation has seen significant positive performance, up over 44% inclusive of dividends since January 19, 2023. The company has outperformed with good overall investment performance, showing resilience towards macro challenges. Despite recent growth, Cabot is now considered a "Hold" due to valuation concerns and moderate upside potential. Read the full article on Seeking Alpha
Analyseartikel Jul 18

Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43

Cabot Corporation's ( NYSE:CBT ) investors are due to receive a payment of $0.43 per share on 13th of September. Based...
Analyseartikel Jun 23

Cabot (NYSE:CBT) Looks To Prolong Its Impressive Returns

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analyseartikel Jun 09

Why Cabot Corporation (NYSE:CBT) Could Be Worth Watching

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw a double-digit share price...
Analyseartikel May 24

Cabot's (NYSE:CBT) Dividend Will Be Increased To $0.43

The board of Cabot Corporation ( NYSE:CBT ) has announced that it will be paying its dividend of $0.43 on the 14th of...
Seeking Alpha May 16

Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward

Summary Cabot Corporation's stock has returned approximately 38% since our 'Buy' recommendation in January. The company's Q2 earnings report showed impressive growth in both Performance Chemicals and the Reinforcement Materials business in particular. Cabot's cash flow is driving its financials, allowing for increased dividends and stock buybacks, and its forward-looking fundamentals remain bullish. Read the full article on Seeking Alpha
Analyseartikel May 13

Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit

The market for Cabot Corporation's ( NYSE:CBT ) stock was strong after it released a healthy earnings report last week...
Analyseartikel May 10

Cabot's (NYSE:CBT) Upcoming Dividend Will Be Larger Than Last Year's

Cabot Corporation's ( NYSE:CBT ) dividend will be increasing from last year's payment of the same period to $0.43 on...

Opbrengsten en kosten

Hoe Cabot geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NYSE:CBT Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
31 Mar 263,57528126256
31 Dec 253,60730626056
30 Sep 253,71332625857
30 Jun 253,81541826360
31 Mar 253,90842626961
31 Dec 243,99141728062
30 Sep 243,99437428163
30 Jun 243,95847028060
31 Mar 243,91044326959
31 Dec 233,92443326059
30 Sep 233,93143725357
30 Jun 234,07830024257
31 Mar 234,25931523758
31 Dec 224,31834824655
30 Sep 224,32120625555
30 Jun 224,11314229056
31 Mar 223,88113030656
31 Dec 213,6319829755
30 Sep 213,40924729356
30 Jun 213,164-5431557
31 Mar 212,765-14429654
31 Dec 202,633-21929257
30 Sep 202,614-23829557
30 Jun 202,7826524654
31 Mar 203,10910326157
31 Dec 193,24312726858
30 Sep 193,33715527060
30 Jun 193,36021728165
31 Mar 193,36927328266
31 Dec 183,3437729567
30 Sep 183,242-11429566
30 Jun 183,115-13628264
31 Mar 182,966-17727961
31 Dec 172,8266926359
30 Sep 172,71724625857
30 Jun 172,61322527053
31 Mar 172,52923426951
31 Dec 162,41920926449
30 Sep 162,41114526648
30 Jun 162,46313625149
31 Mar 162,536-36625652
31 Dec 152,662-38826354
30 Sep 152,871-33627158
30 Jun 153,111-34828158

Kwaliteitswinsten: CBT heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (7.9%) CBT } zijn lager dan vorig jaar (10.9%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: CBT is de afgelopen 5 jaar winstgevend geworden en heeft de winst met 25.8% per jaar laten groeien.

Versnelling van de groei: De winstgroei CBT is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.

Winst versus industrie: CBT had het afgelopen jaar een negatieve winstgroei ( -34% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Chemicals ( 0.1% ).


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 19.4% ) van CBT wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/06/11 01:22
Aandelenkoers aan het einde van de dag2026/06/11 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/09/30

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Cabot Corporation wordt gevolgd door 11 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank